GATA5 and neoplasm: Moreover, we carried out a multivariate analysis demonstrating that mRNA expression of GATA5 (p = 0.12, HR = 0.32; 95% CI: 0.07–1.34) is not significantly associated with RFS including the covariates status of advance disease (p = 0.29, HR = 0.18; 95% CI: 0.01-4.41), status of metastasis (p = 0.14, HR = 6.60; 95% CI: 0.55–78.68), tumor grade p = 0.002, HR = 0.09; 95% CI: 2.46–56.14, age (p = 0.36, HR = 2.54; 95% CI: 0.05–2.85) and gender (p = 0.39, HR = 2.03; 95% CI: 0.39–10.38).